This article on the Motley Fool reads like a commercial for a Big Pharma drug — complete with a partial reading of the side effects. Oh wait — it is.
I continue to think there’s a potential market for obesity drugs, but the drugmakers are going to have to convince doctors that the benefits justify the side effects and secure insurance coverage so patients can afford to take them.
Motley used to be a good website before it became a giant ad for “own these 3 stocks” and “buy our newsletters to get rich.” Now they got some Pharma PhD hawking obesity drugs like a vacuum cleaner salesman with nary a single stop to take a breath and critically assess anything that could be wrong with the concept of treating the symptom with life-sucking pills instead of addressing the very obvious causes that will continue to destroy the health and life of generations of folks.